These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 25678784)

  • 1. Reversal of corticosteroid insensitivity by p38 MAPK inhibition in peripheral blood mononuclear cells from COPD.
    Khorasani N; Baker J; Johnson M; Chung KF; Bhavsar PK
    Int J Chron Obstruct Pulmon Dis; 2015; 10():283-91. PubMed ID: 25678784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic effects of p38 mitogen-activated protein kinase inhibition with a corticosteroid in alveolar macrophages from patients with chronic obstructive pulmonary disease.
    Armstrong J; Harbron C; Lea S; Booth G; Cadden P; Wreggett KA; Singh D
    J Pharmacol Exp Ther; 2011 Sep; 338(3):732-40. PubMed ID: 21610141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of p38 MAPK inhibition on corticosteroid suppression of cytokine release in severe asthma.
    Bhavsar P; Khorasani N; Hew M; Johnson M; Chung KF
    Eur Respir J; 2010 Apr; 35(4):750-6. PubMed ID: 19840967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P38 MAPK and glucocorticoid receptor crosstalk in bronchial epithelial cells.
    Lea S; Li J; Plumb J; Gaffey K; Mason S; Gaskell R; Harbron C; Singh D
    J Mol Med (Berl); 2020 Mar; 98(3):361-374. PubMed ID: 31974640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential anti-inflammatory effects of budesonide and a p38 MAPK inhibitor AZD7624 on COPD pulmonary cells.
    Higham A; Karur P; Jackson N; Cunoosamy DM; Jansson P; Singh D
    Int J Chron Obstruct Pulmon Dis; 2018; 13():1279-1288. PubMed ID: 29719383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Restoration of corticosteroid sensitivity by p38 mitogen activated protein kinase inhibition in peripheral blood mononuclear cells from severe asthma.
    Mercado N; Hakim A; Kobayashi Y; Meah S; Usmani OS; Chung KF; Barnes PJ; Ito K
    PLoS One; 2012; 7(7):e41582. PubMed ID: 22911818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of lipopolysaccharide-stimulated chronic obstructive pulmonary disease macrophage inflammatory gene expression by dexamethasone and the p38 mitogen-activated protein kinase inhibitor N-cyano-N'-(2-{[8-(2,6-difluorophenyl)-4-(4-fluoro-2-methylphenyl)-7-oxo-7,8-dihydropyrido[2,3-d] pyrimidin-2-yl]amino}ethyl)guanidine (SB706504).
    Kent LM; Smyth LJ; Plumb J; Clayton CL; Fox SM; Ray DW; Farrow SN; Singh D
    J Pharmacol Exp Ther; 2009 Feb; 328(2):458-68. PubMed ID: 19004925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p38 Mitogen-activated protein kinase-induced glucocorticoid receptor phosphorylation reduces its activity: role in steroid-insensitive asthma.
    Irusen E; Matthews JG; Takahashi A; Barnes PJ; Chung KF; Adcock IM
    J Allergy Clin Immunol; 2002 Apr; 109(4):649-57. PubMed ID: 11941315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roflumilast N-oxide reverses corticosteroid resistance in neutrophils from patients with chronic obstructive pulmonary disease.
    Milara J; Lluch J; Almudever P; Freire J; Xiaozhong Q; Cortijo J
    J Allergy Clin Immunol; 2014 Aug; 134(2):314-22. PubMed ID: 24636089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corticosteroid insensitive alveolar macrophages from asthma patients; synergistic interaction with a p38 mitogen-activated protein kinase (MAPK) inhibitor.
    Lea S; Harbron C; Khan N; Booth G; Armstrong J; Singh D
    Br J Clin Pharmacol; 2015 May; 79(5):756-66. PubMed ID: 25358442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corticosteroid effects on COPD alveolar macrophages: dependency on cell culture methodology.
    Higham A; Lea S; Ray D; Singh D
    J Immunol Methods; 2014 Mar; 405(100):144-53. PubMed ID: 24530567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of corticosteroid insensitivity in COPD alveolar macrophages exposed to NTHi.
    Khalaf RM; Lea SR; Metcalfe HJ; Singh D
    Respir Res; 2017 Apr; 18(1):61. PubMed ID: 28420398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restoration of Corticosteroid Sensitivity in Chronic Obstructive Pulmonary Disease by Inhibition of Mammalian Target of Rapamycin.
    Mitani A; Ito K; Vuppusetty C; Barnes PJ; Mercado N
    Am J Respir Crit Care Med; 2016 Jan; 193(2):143-53. PubMed ID: 26426522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roflumilast improves corticosteroid resistance COPD bronchial epithelial cells stimulated with toll like receptor 3 agonist.
    Milara J; Morell A; Ballester B; Sanz C; Freire J; Qian X; Alonso-Garcia M; Morcillo E; Cortijo J
    Respir Res; 2015 Feb; 16(1):12. PubMed ID: 25652132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p38 mitogen-activated protein kinase-γ inhibition by long-acting β2 adrenergic agonists reversed steroid insensitivity in severe asthma.
    Mercado N; To Y; Kobayashi Y; Adcock IM; Barnes PJ; Ito K
    Mol Pharmacol; 2011 Dec; 80(6):1128-35. PubMed ID: 21917909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defects of protein phosphatase 2A causes corticosteroid insensitivity in severe asthma.
    Kobayashi Y; Mercado N; Barnes PJ; Ito K
    PLoS One; 2011; 6(12):e27627. PubMed ID: 22205926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of erythromycin and dexamethasone improves corticosteroid sensitivity induced by CSE through inhibiting PI3K-δ/Akt pathway and increasing GR expression.
    Sun XJ; Li ZH; Zhang Y; Zhou G; Zhang JQ; Deng JM; Bai J; Liu GN; Li MH; MacNee W; Zhong XN; He ZY
    Am J Physiol Lung Cell Mol Physiol; 2015 Jul; 309(2):L139-46. PubMed ID: 25957293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corticosteroid insensitivity is reversed by formoterol via phosphoinositide-3-kinase inhibition.
    Rossios C; To Y; Osoata G; Ito M; Barnes PJ; Ito K
    Br J Pharmacol; 2012 Oct; 167(4):775-86. PubMed ID: 22251095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro modeling of COPD inflammation and limitation of p38 inhibitor - SB203580.
    Meng A; Zhang X; Wu S; Wu M; Li J; Yan X; Kopec-Harding K; Wu J
    Int J Chron Obstruct Pulmon Dis; 2016; 11():909-17. PubMed ID: 27199554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhaled long-acting β2 agonists enhance glucocorticoid receptor nuclear translocation and efficacy in sputum macrophages in COPD.
    Haque R; Hakim A; Moodley T; Torrego A; Essilfie-Quaye S; Jazrawi E; Johnson M; Barnes PJ; Adcock IM; Usmani OS
    J Allergy Clin Immunol; 2013 Nov; 132(5):1166-73. PubMed ID: 24070494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.